The North America cardiovascular devices market is expected to reach US$ 27,058.9 Mn in 2027 from US$ 15,299.7 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.
The growth of the market is driven by the factors such as, rising developments for cardiovascular devices and rising geriatric population. However, the cardiovascular devices market is likely to slower down its growth due to the rigorous regulations for approval in the region.
The rising population of the elderly people is the major cause of the heart diseases in the region. The heart diseases are mostly pone to the elderly people due to weak immunity and major other health problems. For instance, the number of Americans above the age of 65 and older is anticipated to grow more than double from US$ 46 million in 2016 to above US$ 98 million by 2060, and the 65-and-older age group’s share in the world’s population will grow around 24%from 15 percent. In addition, as per the report of UN, in 2012, the number of older persons (aged 60 years or over) is expected to more than double. The number is estimated to reach around 2 billion in 2050 from 841 million in 2013. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050, and will rise above US$ 3.1 billion in 2100. The elderly population are more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. The major reason for the disease are related to the structural and functional changes in the cardiovascular system associated with the aging.
The rising geriatric population in the region leads to the cardiovascular disease which will require the cardiovascular devices for their treatment. These factors are likely to grow the market in the coming years.
US is expected to lead the market in the North America region owing to increasing prevalence of cardiovascular diseases, rising incidences of the high blood pressure and growing R&D in medical technology in the country. Moreover, the country has several hospitals, super specialty hospitals which offers diagnostic and treatment services for the cardiovascular diseases. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
Maxico Cardiovascular Devices Market Revenue and Forecasts to 2027 ( US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA CARDIOVASCULAR DEVICES – MARKET SEGMENTATION
By Device
- Electrocardiography (ECG)
- Pacemaker
- Stent
- Defibrillator
- Cardiac Catheter
- Guidewire
- Heart Valve
- Event Monitor
- Others
By Application
- Coronary Heart Disease
- Sudden Cardiac Arrest
- Stroke
- Cerebrovascular Heart Disease
- Others
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cardiac Centers
By Geography
North America
- US
- Canada
- Mexico
Company Profiles
- Medtronic
- Boston Scientific Corporation
- Abbott
- Biosense Webster, Inc. (Johnson and Johnson)
- General Electric Company
- Koninklijke Philips N.V
- Siemens AG,
- BD
- B. Braun Melsungen AG
- Edwards Lifesciences Corporation.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Device, Application, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. North America Cardiovascular Devices Market – Key Takeaways
3. North America Cardiovascular Devices Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Cardiovascular Devices Market – By Device
3.2.2 North America Cardiovascular Devices Market – By Application
3.2.3 North America Cardiovascular Devices Market – By End User
3.2.4 North America Cardiovascular Devices Market – By Country
3.3 PEST Analysis
4. North America Cardiovascular Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Developments For Cardiovascular Devices
4.1.2 Rising Geriatric Population
4.2 Key Market Restraints
4.2.1 Rigorous Regulations For Approval
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism In Mexico
4.4 Future Trends
4.4.1 Continuous Technological Advancements
4.5 Impact Analysis
5. Cardiovascular Devices Market – North America Analysis
5.1 North America Cardiovascular Devices Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.2.1 Medtronic
5.2.2 Abbott
6. North America Cardiovascular Devices Market Analysis – By Device
6.1 Overview
6.2 North America Cardiovascular Devices Market By Device, 2018 & 2027 (%)
6.3 North America Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)
6.4 North America Cardiovascular Devices Market Volume And Forecasts To 2027, By Device (Units)
6.5 Event Monitor Market
6.5.1 Overview
6.5.2 Event Monitor Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Electrocardiography (ECG) Market
6.6.1 Overview
6.6.2 Electrocardiography (ECG) Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Cardiac Catheter Market
6.7.1 Overview
6.7.2 Cardiac Catheter Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Stent Market
6.8.1 Overview
6.8.2 Stent Market Revenue and Forecast to 2027 (US$ Mn)
6.9 Defibrillator Market
6.9.1 Overview
6.9.2 Defibrillator Market Revenue and Forecast to 2027 (US$ Mn)
6.10 Guidewire Market
6.10.1 Overview
6.10.2 Guidewire Market Revenue and Forecast to 2027 (US$ Mn)
6.11 Pacemaker Market
6.11.1 Overview
6.11.2 Pacemaker Market Revenue and Forecast to 2027 (US$ Mn)
6.12 Heart Valve Market
6.12.1 Overview
6.12.2 Heart Valve Market Revenue and Forecast to 2027 (US$ Mn)
6.13 Other Devices Market
6.13.1 Overview
6.13.2 Other Devices Market Revenue and Forecast to 2027 (US$ Mn)
7. North America Cardiovascular Devices Market Analysis – By Application
7.1 Overview
7.2 North America Cardiovascular Devices Market, By Application, 2018 & 2027 (%)
7.3 North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
7.4 Coronary Heart Disease Market
7.4.1 Overview
7.4.2 Coronary Heart Disease Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Stroke Market
7.5.1 Overview
7.5.2 Stroke Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Sudden Cardiac Arrest Market
7.6.1 Overview
7.6.2 Sudden Cardiac Arrest Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cerebrovascular Heart Disease Market
7.7.1 Overview
7.7.2 Cerebrovascular Heart Disease Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Others Market
7.8.1 Overview
7.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Cardiovascular Devices Market Analysis – By End User
8.1 Overview
8.2 North America Cardiovascular Devices Market, By End User, 2018 & 2027 (%)
8.3 North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
8.4 Hospitals Market
8.4.1 Overview
8.4.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Cardiac Centers Market
8.5.1 Overview
8.5.2 Cardiac Centres Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Ambulatory Surgery Centers Market
8.6.1 Overview
8.6.2 Ambulatory Surgery Centers Market Revenue and Forecast to 2027 (US$ Mn)
9. North America Cardiovascular Devices Market Revenue and Forecasts To 2027
9.1 Overview
9.2 North America Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
9.3 North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Device (US$ Mn)
9.4 North America Cardiovascular Devices Market Volume and Forecasts To 2027, By Device (Units)
9.5 North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
9.6 North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
9.7 North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Country (%)
9.8 US Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
9.8.1 US Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
9.8.2 US Cardiovascular Devices Market Revenue and Forecasts to 2027, By Device (US$ Mn)
9.8.3 US Cardiovascular Devices Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.8.4 US Cardiovascular Devices Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.9 Canada Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
9.9.1 Canada Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
9.9.2 Canada Cardiovascular Devices Market Revenue and Forecasts to 2027, By Device (US$ Mn)
9.9.3 Canada Cardiovascular Devices Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.9.4 Canada Cardiovascular Devices Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.10 Mexico Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
9.10.1 Mexico Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
9.10.2 Mexico Cardiovascular Devices Market Revenue and Forecasts to 2027, By Device (US$ Mn)
9.10.3 Mexico Cardiovascular Devices Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.10.4 Mexico Cardiovascular Devices Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10. Cardiovascular Devices Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies Done by the Companies in the Market, (%)
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch & Up Gradation
10.3.3 Approvals
10.3.4 Others Developments
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Acquisition
10.4.3 Collaboration & Agreement
11. Cardiovascular Devices Market – Key Company Profiles
11.1 Medtronic
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Information
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Biosense Webster, Inc (Johnson and Johnson)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 General Electric Company
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Koninklijke Philips N.V.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT ANALYSIS
11.6.6 Key Developments
11.7 Siemens Ag
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 BD
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 B. Braun Melsungen AG
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Edwards Lifesciences Corporation
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. Recent Approvals For Cardiovascular Devices in the Market
Table 2. North America Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)
Table 3. North America Cardiovascular Devices Market Volume And Forecasts To 2027, By Device (Units)
Table 4. North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 5. North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 6. North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Device (US$ Mn)
Table 7. North America Cardiovascular Devices Market Volume and Forecasts To 2027, By Device (Units)
Table 8. North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 9. North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 10. US Cardiovascular Devices Market Revenue and Forecasts To 2027, By Device (US$ Mn)
Table 11. US Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 12. US Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 13. Canada Cardiovascular Devices Market Revenue and Forecasts To 2027, By Device (US$ Mn)
Table 14. Canada Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 15. Canada Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 16. Mexico Cardiovascular Devices Market Revenue and Forecasts To 2027, By Device (US$ Mn)
Table 17. Mexico Cardiovascular Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 18. Mexico Cardiovascular Devices Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 19. Recent Product Launch & Upgradation in the Cardiovascular Devices Market
Table 20. Recent Approvals in the Cardiovascular Devices Market
Table 21. Recent Others Development’s in the Cardiovascular Devices Market
Table 22. Acquisitions in the Cardiovascular Devices Market
Table 23. Collaboration in the Cardiovascular Devices Market
Table 24. Glossary Of Terms, Cardiovascular Devices Market
LIST OF FIGURES
Figure 1.US Cardiovascular Devices Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2.North America Cardiovascular Devices Market By Device, Market Share (%), 2018
Figure 3.North America Cardiovascular Devices Market By Application, Market Share (%), 2018
Figure 4.North America Cardiovascular Devices Market By End User, Market Share (%), 2018
Figure 5.Cardiovascular Devices Market Segmentation
Figure 6.North America PEST Analysis
Figure 7.Cardiovascular Devices Market Impact Analysis of Drivers & Restraints
Figure 8.North America Cardiovascular Devices Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 9.Market Positioning Of Key Player In North America Cardiovascular Devices Market
Figure 10. North America Cardiovascular Devices Market, By Device 2018 & 2027 (%)
Figure 11. Event Monitor Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Electrocardiography (ECG) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Cardiac Catheter Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Stent Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Defibrillator Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Guidewire Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Pacemaker Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Heart Valve Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 19. Other Devices Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 20. North America Cardiovascular Devices Market By Application, 2018 & 2027 (%)
Figure 21. Coronary Heart Disease Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 22. Stroke Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 23. Sudden Cardiac Arrest Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 24. Cerebrovascular Heart Disease Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 25. Others Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 26. North America Cardiovascular Devices Market By End User, 2018 & 2027 (%)
Figure 27. Hospitals Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 28. Cardiac Centres Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 29. Ambulatory Surgery Centers Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 30. North America Cardiovascular Devices Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 31. North America Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 32. North America Cardiovascular Devices Market Revenue and Forecasts To 2027, By Country (%)
Figure 33. US Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 34. Canada Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 35. Mexico Cardiovascular Devices Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
Figure 37. Organic Growth Strategies in the Cardiovascular Devices Market, 2016-2019
Figure 38. Inorganic Growth Strategies in the Cardiovascular Devices Market, 2016-2019
The List of Companies - North America Cardiovascular Devices Market
- Medtronic
- Boston Scientific Corporation
- Abbott
- Biosense Webster, Inc. (Johnson and Johnson)
- General Electric Company
- Koninklijke Philips N.V
- Siemens AG,
- BD
- B. Braun Melsungen AG
- Edwards Lifesciences Corporation.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Cardiovascular Devices Market
Jul 2019
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jul 2019
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jul 2019
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)